Japan-based Chugai Pharmaceutical has revealed plans to expand its research subsidiary in Singapore, Chugai Pharmabody Research (CPR), in order to enhance its drug discovery capabilities. As part of the expansion, the company is extending the […]
Merck has secured approval from the China National Drug Administration (CNDA) for the use of its Keytruda medicine to treat adults suffering from unresectable or metastatic melanoma. Keytruda is an anti-PD-1, humanised monoclonal antibody designed […]
The UK Government is set to legalise cannabis-derived medicinal products over the coming months, following Home Secretary Sajid Javid’s decision to reschedule the medicines based on a two-part review commissioned last month. The move to […]
Pierre Fabre has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the use of Braftovi (encorafenib) and Mektovi (binimetinib) combination to treat […]
An exclusive interview with Dr.Antonio DiGiandomenico, Principal Scientist, MedImmune has beenreleased SMi Reports: An exclusive interview with Dr.Antonio DiGiandomenico, Principal Scientist at MedImmune on challenges and his vision for the future of AMR R&D has […]